StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)

Close on Nov 17, 2026Market cap $14.40BP/E –Yield –

Glaukos operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Glaukos's operating cash flow for the twelve months ending Sep 30, 2026 was $47.71M. For fiscal 2025 it was -$14.79M. The highest annual figure on record is $26.09M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.79M–
FY2024Dec 31, 2024-$61.32M–
FY2023Dec 31, 2023-$57.76M–
FY2022Dec 31, 2022-$33.08M-233.9%
FY2021Dec 31, 2021$24.71M–
FY2020Dec 31, 2020-$22.99M–
FY2019Dec 31, 2019-$369.00K-102.0%
FY2018Dec 31, 2018$18.86M-27.7%
FY2017Dec 31, 2017$26.09M+112.0%
FY2016Dec 31, 2016$12.31M–
FY2015Dec 31, 2015-$2.19M–
FY2014Dec 31, 2014-$7.11M–
FY2013Dec 31, 2013-$13.31M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$38.57M–
Q2 FY2026Jun 30, 2026$14.82M+112.4%
Q1 FY2026Mar 31, 2026-$12.53M–
Q4 FY2025Dec 31, 2025$6.84M+1249.7%
Q3 FY2025Sep 30, 2025-$10.09M–
Q2 FY2025Jun 30, 2025$6.98M–
Q1 FY2025Mar 31, 2025-$18.52M–
Q4 FY2024Dec 31, 2024$507.00K–
Q3 FY2024Sep 30, 2024-$9.59M–
Q2 FY2024Jun 30, 2024-$18.37M–
Q1 FY2024Mar 31, 2024-$33.87M–
Q4 FY2023Dec 31, 2023-$10.67M–
Q3 FY2023Sep 30, 2023-$8.17M–
Q2 FY2023Jun 30, 2023-$8.16M–
Q1 FY2023Mar 31, 2023-$30.76M-414.8%
Q4 FY2022Dec 31, 2022-$4.14M–
Q3 FY2022Sep 30, 2022-$26.52M-249.0%
Q2 FY2022Jun 30, 2022-$12.21M-265.1%
Q1 FY2022Mar 31, 2022$9.77M+133.9%
Q4 FY2021Dec 31, 2021-$4.65M-143.9%
Q3 FY2021Sep 30, 2021$17.79M–
Q2 FY2021Jun 30, 2021$7.39M–
Q1 FY2021Mar 31, 2021$4.18M–
Q4 FY2020Dec 31, 2020$10.60M–
Q3 FY2020Sep 30, 2020-$9.57M–
Q2 FY2020Jun 30, 2020-$10.92M-265.4%
Q1 FY2020Mar 31, 2020-$13.10M-6397.6%
Q4 FY2019Dec 31, 2019-$4.19M-124.5%
Q3 FY2019Sep 30, 2019-$2.99M-168.5%
Q2 FY2019Jun 30, 2019$6.60M+72.6%
Q1 FY2019Mar 31, 2019$208.00K–
Q4 FY2018Dec 31, 2018$17.13M+37.4%
Q3 FY2018Sep 30, 2018$4.36M-37.6%
Q2 FY2018Jun 30, 2018$3.83M-11.3%
Q1 FY2018Mar 31, 2018-$6.45M-377.4%
Q4 FY2017Dec 31, 2017$12.46M+280.2%
Q3 FY2017Sep 30, 2017$6.99M–
Q2 FY2017Jun 30, 2017$4.31M–
Q1 FY2017Mar 31, 2017$2.33M–
Q4 FY2016Dec 31, 2016$3.28M–

More Glaukos figures

See a number that looks wrong?